Vorsetuzumab (Anti-Human CD70 Recombinant Antibody) is a monoclonal antibody that targets the CD70 antigen. It exhibits anticancer activity by enhancing macrophage-associated phagocytosis of kidney cancer cells and inhibiting Burkitt lymphoma.
Purity:
99.29%
CAS Number:
[1165740-62-4]
Target:
Immunology/Inflammation related|||TNF
* VAT and and shipping costs not included. Errors and price changes excepted